Beta blockers to reduce mortality and cardiovascular complications after noncardiac surgery
There's a lot of talk about using beta blockers to reduce mortality and cardiovascular complications after noncardiac surgery.
Researchers say this could save 25,000 lives a year.
Atenolol (Tenormin) is being given to surgical patients with CHD...or those at risk for CHD.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote